Interleukin-2 in clinical trials : Other factors to be considered. Authors' replyNANNINI, Esteban C; EMERY, Sean; LANE, H. Clifford et al.The Journal of infectious diseases. 2001, Vol 183, Num 4, pp 679-680, issn 0022-1899Article

Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2BOSCO SHANG WANG; HEACOCK, E. H; CHANG-XUE ZHENG et al.Transplantation. 1982, Vol 33, Num 4, pp 454-456, issn 0041-1337Article

Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration : role of nitric oxideMORENO, Susana E; ALVES-FILHO, José C; BERTOZI, Giuliana et al.British journal of pharmacology. 2006, Vol 148, Num 8, pp 1060-1066, issn 0007-1188, 7 p.Article

Secondary structure of interleukin-2 (Ala 125) in unfolded stateARAKAWA, T; KENNEY, W. C.International journal of peptide & protein research. 1988, Vol 31, Num 5, pp 468-473, issn 0367-8377Article

Formulation of liposomes associated with recombinant interleukin-2: effect on interleukin-2 activity : Drug delivery and drug efficacyPELLEQUER, Yann; OLLIVON, Michel; BARRATT, Gillian et al.Biomedicine & pharmacotherapy. 2004, Vol 58, Num 3, pp 162-167, issn 0753-3322, 6 p.Article

Bases cellulaires et moléculaires du développement de l'éosinophilie dans les syndromes hyperéosinophiliques = Cellular and molecular basis of eosinophilia development in hypereosinophilic syndromePlumas, Joël; Capron, André.1992, 225 p.Thesis

Interleukin 2 and psoriasisLEE, R. E; GASPARI, A. A; LOTZE, M. T et al.Archives of dermatology (1960). 1988, Vol 124, Num 12, pp 1811-1815, issn 0003-987XArticle

Augmentation of antileukemia lytic activity by OKT3 monoclonal antibody: synergism of OKT3 and interleukin-2LOTZOVA, E; SAVARY, C. A; HERBERMAN, R. B et al.Natural immunity and cell growth regulation. 1987, Vol 6, Num 5, pp 219-223, issn 0254-7600Article

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumorsBOSLY, A; GUILLAUME, T; SYMANN, M et al.GUILLAUME, T; Experimental hematology. 1992, Vol 20, Num 8, pp 962-968, issn 0301-472XArticle

Serum interleukin-2 receptor levels measured by enzyme immunoassay in heart and kidney transplanted patientsDE MARIA, R; ZUCCHELLI, G. C; CLERICO, A et al.International journal of tissue reactions. 1989, Vol 11, Num 5, pp 261-265, issn 0250-0868, 5 p.Article

Chemical cross-linking of IL-2 to high affinity receptors present on glycerol-loaded T cells and membranes prepared from them yields only IL-2/P55 (Tac) complexesSIEKIERKA, J. J; DEGUDICIBUS, S; WADSWORTH, J et al.Annals of the New York Academy of Sciences. 1988, Vol 546, pp 230-231, issn 0077-8923Conference Paper

Modulation of the response to interleukin 2 in recipients of donor-specific transfusions under azathioprine immunosuppressionTYLER, J. D; ANDERSON, C. B; SICARD, G. A et al.Transplantation. 1986, Vol 42, Num 5, pp 502-506, issn 0041-1337Article

The effects of hemorrhage and trauma on interleukin 2 productionABRAHAM, E; REGAN, R. F.Archives of surgery (Chicago, IL. 1960). 1985, Vol 120, Num 12, pp 1341-1344, issn 0004-0010Article

Infection after subcutaneous interleukin-2BUTER, J; DE VRIES, E. G. E; SLEIJFER, D. T et al.Lancet (British edition). 1992, Vol 339, Num 8792, issn 0140-6736, p. 552Article

Ascites induced by interleukin-2 in the treatment of renal cancerTHOMAS, H; VALLIS, K. A; WILLIAMS, G et al.British journal of urology (Print). 1990, Vol 65, Num 3, pp 303-305, issn 0007-1331Article

Minireview serum inhibitors of interleukin-2KUCHARZ, E. J; GOODWIN, J. S.Life sciences (1973). 1988, Vol 42, Num 16, pp 1485-1491, issn 0024-3205Article

Structure-activity studies of interleukin-2COHEN, F. E; KOSEN, P. A; KUNTZ, I. D et al.Science (Washington, D.C.). 1986, Vol 234, Num 4774, pp 349-352, issn 0036-8075Article

Effect of interleukin-2 on the inhibition of the human mixed lymphocyte reaction (MLR) by azathioprineSZAWLOWSKI, P. W. S; MADDOCKS, J. L.British journal of clinical pharmacology. 1985, Vol 20, Num 2, pp 107-110, issn 0306-5251Article

The phylogeny of interleukin-2WATKINS, D; COHEN, N.Developmental and comparative immunology. 1985, Vol 9, Num 4, pp 819-824, issn 0145-305XArticle

Interleukin-2-unresponsive immune defects in good syndrome: Letter to the EditorYANG, Otto O; KELESIDIS, Theodoros.Clinical immunology (Orlando, Fla. Print). 2010, Vol 135, Num 3, pp 496-498, issn 1521-6616, 3 p.Article

Increased production of interleukin-2 and IL-2 receptor in primary IgA nephropathySCHENA, F. P; MASTROLITTI, G; JIRILLO, E et al.Kidney international. 1989, Vol 35, Num 3, pp 875-879, issn 0085-2538Article

Response of human glioblastoma cells to recombinant interleukin-2BENVENISTE, E. N; TOZAWA, H; GASSON, J. C et al.Journal of neuroimmunology. 1988, Vol 17, Num 4, pp 301-314, issn 0165-5728Article

Reduction of excessive background counts in an IL-2 microassay by incubation of indicator cells at 37°CMICHALSKI, J. P; MCCOMBS, C. C.Journal of immunological methods. 1985, Vol 78, Num 1, pp 159-160, issn 0022-1759Article

The multichain interleukin-2 receptor : a target for immunotherapyWALDMAN, T. A; PASTAN, I. H; GANSOW, O. A et al.Annals of internal medicine. 1992, Vol 116, Num 2, pp 148-160, issn 0003-4819Article

Interleukin-2 : a possible trigger for autoimmunityGONZALO, J. A; CUENDE, E; ALES-MARTINEZ, J et al.International archives of allergy and applied immunology. 1992, Vol 97, Num 4, pp 251-257, issn 0020-5915Article